Search Results - "Rizik, David"

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial by Kereiakes, Dean J, Ellis, Stephen G, Metzger, Christopher, Caputo, Ronald P, Rizik, David G, Teirstein, Paul S, Litt, Marc R, Kini, Annapoorna, Kabour, Ameer, Marx, Steven O, Popma, Jeffrey J, McGreevy, Robert, Zhang, Zhen, Simonton, Charles, Stone, Gregg W

“…The Absorb everolimus-eluting poly-L-lactic acid-based bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support functions…”
Get full text

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease by Ellis, Stephen G, Kereiakes, Dean J, Metzger, D. Christopher, Caputo, Ronald P, Rizik, David G, Teirstein, Paul S, Litt, Marc R, Kini, Annapoorna, Kabour, Ameer, Marx, Steven O, Popma, Jeffrey J, McGreevy, Robert, Zhang, Zhen, Simonton, Charles, Stone, Gregg W

“…In a randomized trial involving 2008 patients with coronary disease, an everolimus-eluting bioresorbable scaffold was noninferior to an everolimus-eluting…”
Get full text

Intervention for aortic stenosis complicated by shock: Focus on the ventricle by Rizik, David G., Goldstein, James A.

“…Key Points TAVR effective in CS, but mortality still high and outcomes determined by non‐procedural factors AS with intact LV ejection fraction rarely induces…”
Get full text

Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial by Kereiakes, Dean J, Ellis, Stephen G, Metzger, D Christopher, Caputo, Ronald P, Rizik, David G, Teirstein, Paul S, Litt, Marc R, Kini, Annapoorna, Kabour, Ameer, Marx, Steven O, Popma, Jeffrey J, Tan, Siok Hwee, Ediebah, Divine E, Simonton, Charles, Stone, Gregg W

“…BACKGROUND:The Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support similar to those of metallic…”
Get full text

Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial by Feldman, Ted E, Reardon, Michael J, Rajagopal, Vivek, Makkar, Raj R, Bajwa, Tanvir K, Kleiman, Neal S, Linke, Axel, Kereiakes, Dean J, Waksman, Ron, Thourani, Vinod H, Stoler, Robert C, Mishkel, Gregory J, Rizik, David G, Iyer, Vijay S, Gleason, Thomas G, Tchétché, Didier, Rovin, Joshua D, Buchbinder, Maurice, Meredith, Ian T, Götberg, Matthias, Bjursten, Henrik, Meduri, Christopher, Salinger, Michael H, Allocco, Dominic J, Dawkins, Keith D

“…IMPORTANCE: Transcatheter aortic valve replacement (TAVR) is established for selected patients with severe aortic stenosis. However, limitations such as…”
Get full text

Urgent mechanical circulatory support and transcatheter mitral valve repair for refractory hemodynamic compromise by Rizik, David G., Burke, Robert F., Goldstein, James A.

“…Patients presenting with hemodynamic instability attributable to left ventricular systolic dysfunction and concomitant severe mitral regurgitation (MR) are…”
Get full text

Comprehensive radiation shield minimizes operator radiation exposure in coronary and structural heart procedures by Rizik, David G., Gosselin, Kevin P., Burke, Robert F., Goldstein, James A.

“…This study evaluated the efficacy of a novel comprehensive shield designed to minimize radiation exposure (RE) to Physicians performing coronary and structural…”
Get full text

Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial by Meduri, Christopher U, Kereiakes, Dean J, Rajagopal, Vivek, Makkar, Raj R, O'Hair, Daniel, Linke, Axel, Waksman, Ron, Babliaros, Vasilis, Stoler, Robert C, Mishkel, Gregory J, Rizik, David G, Iyer, Vijay S, Schindler, John, Allocco, Dominic J, Meredith, Ian T, Feldman, Ted E, Reardon, Michael J

“…Background As transcatheter aortic valve replacement expands to younger and/or lower risk patients, the long-term consequences of permanent pacemaker…”
Get full text

Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow) by Stone, Gregg W, Maehara, Akiko, Muller, James E, Rizik, David G, Shunk, Kendrick A, Ben-Yehuda, Ori, Genereux, Philippe, Dressler, Ovidiu, Parvataneni, Rupa, Madden, Sean, Shah, Priti, Brilakis, Emmanouil S, Kini, Annapoorna S

“…This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies…”
Get full text

Zero Radiation in the Cardiac Catheterization Laboratory: An Aspirational Goal or Moral Imperative? by Rizik, David G, Rizik, Michael B

Get full text

2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques by Yamamoto, Myong Hwa, Maehara, Akiko, Stone, Gregg W., Kini, Annapoorna S., Brilakis, Emmanouil S., Rizik, David G., Shunk, Kendrick, Powers, Eric R., Tobis, Jonathan M., Maini, Brijeshwar S., Dixon, Simon R., Goldstein, James A., Petersen, John L., Généreux, Philippe, Shah, Priti R., Crowley, Aaron, Nicholls, Stephen J., Mintz, Gary S., Muller, James E., Weisz, Giora

“…Autopsy studies suggest that implanting stents in lipid-rich plaque (LRP) may be associated with adverse outcomes. The purpose of this study was to evaluate…”
Get full text

Treatment of Aortic Regurgitation With a Novel Device: Results of the J-Valve Early Feasibility Study by Garcia, Santiago, Kaneko, Tsuyoshi, Reardon, Michael, Goel, Sachin, Cohen, David J., Cavalcante, João L., Chuang, Michael L., Hahn, Rebecca T., Latib, Azeem, Waksman, Ron, Rizik, David G., Fail, Peter, Gafoor, Sameer A., Kereiakes, Dean J.

Get full text

Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction by Goldstein, James A, Maini, Brijeshwar, Dixon, Simon R, Brilakis, Emmanouil S, Grines, Cindy L, Rizik, David G, Powers, Eric R, Steinberg, Daniel H, Shunk, Kendrick A, Weisz, Giora, Moreno, Pedro R, Kini, Annapoorna, Sharma, Samin K, Hendricks, Michael J, Sum, Steve T, Madden, Sean P, Muller, James E, Stone, Gregg W, Kern, Morton J

“…BACKGROUND—Percutaneous coronary intervention (PCI) is associated with periprocedural myocardial infarction (MI) in 3% to 15% of cases (depending on the…”
Get full text

The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug-eluting stent: Current concepts and overview of clinical evidence by Rizik, David G., Hermiller, James B., Kereiakes, Dean J.

“…The advent of fully bioresorbable stent technology and specifically the ABSORB™, a bioresorbable vascular scaffold (BVS) stent, is heralded as breakthrough…”
Get full text

Innovative Intra-Aortic Circulatory Support Pump: Novel Hemodynamics by Rizik, David G., Goldstein, James A.

Get full text

Re‐instituting a live cardiology meeting without symptomatic COVID‐19 transmission by Rizik, David G., Rao, Sunil V., Stone, Gregg W., Burke, Robert F., Hermiller, James B., O'Neill, William W.

Get full text

Detection by Near-Infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites in Patients With Acute ST-Segment Elevation Myocardial Infarction by Madder, Ryan D., MD, Goldstein, James A., MD, Madden, Sean P., PhD, Puri, Rishi, MBBS, Wolski, Kathy, MPH, Hendricks, Michael, BS, Sum, Stephen T., PhD, Kini, Annapoorna, MD, Sharma, Samin, MD, Rizik, David, MD, Brilakis, Emmanouil S., MD, PhD, Shunk, Kendrick A., MD, PhD, Petersen, John, MD, Weisz, Giora, MD, Virmani, Renu, MD, Nicholls, Stephen J., MBBS, PhD, Maehara, Akiko, MD, Mintz, Gary S., MD, Stone, Gregg W., MD, Muller, James E., MD

“…Objectives This study sought to describe near-infrared spectroscopy (NIRS) findings of culprit lesions in ST-segment elevation myocardial infarction (STEMI)…”
Get full text

Algorithms for challenging scenarios encountered in transradial intervention by Sawant, Abhishek C., Rizik, David G., Rao, Sunil V., Pershad, Ashish

“…Transradial intervention (TRI) was first introduced by Lucien Campeau in 1989 and since then has created a lasting impact in the field of interventional…”
Get full text

First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease by Rizik, David G., Shah, Maulik G., Burke, Robert F.

“…Drug eluting stents are considered the “gold standard” for the percutaneous treatment of coronary artery disease. Recent publications have suggested that a…”
Get full text

Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials by Rizik, David G, Hermiller, James B, Kereiakes, Dean J.

“…The permanent metal prosthesis common to bare metal stents (BMS) as well as both first‐ and second‐generation drug‐eluting stents (DES) following treatment of…”
Get full text